Oncology
After 'Year of Harvest', Bayer looks to diversify modalities
Bayer Oncology's strategy has led to strong showings in small molecules and radiotherapies. Now they're on the hunt for ADCs, bispecifics, and more.
Patients
Patient centricity in psychiatric management: Bipolar I
Discover what clinicians can do to foster more patient-centred psychiatric care in a Q&A with neuropsychiatric physician assistant Rebecca Barbee.
R&D
Changing Faces: Board of Directors, January 2026
January was a relatively quiet month for Board news, but there were some notable moves here and there.
Sales & Marketing
Sponsored
5 forces reshaping pharma commercialisation in 2026
As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment
Digital
The evolution of leadership for healthcare organisations in ...
Leaders must be adaptive, forward-thinking, and equipped to cultivate environments where humans and AI work together effectively and ethically.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
